Cytokine response to portal endotoxaemia and neutrophil stimulation in obstructive jaundice

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 1, 2012, Pages 25-32

  Badger, Stephen A ^a   Jones, Claire ^a   McCaigue, Mark ^a   Clements, Barry W ^a   Parks, Rowan W ^a   Diamond, Tom ^a   McCallion, Kevin ^a   Taylor, Mark A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cytokines; Obstructive jaundice; Sepsis

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LEUKOCYTE ACTIVATION; LIVER FUNCTION TEST; LIVER INJURY; LIVER SINUSOID; LIVER STRUCTURE; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RAT; RESPIRATORY BURST; SHAM PROCEDURE; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; INFLAMMATION MEDIATORS; INTERLEUKINS; JAUNDICE, OBSTRUCTIVE; LIVER; MALE; MICROSCOPY, ELECTRON; NEUTROPHIL ACTIVATION; NEUTROPHILS; RATS; RATS, WISTAR; RESPIRATORY BURST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82555168345     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834b0dd3     Document Type: Article

References (55)

1. O'Neil S, Hunt J, Filkins J, Gamelli R. Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-alpha and systemic and tissue tumor necrosis factor-alpha levels after endotoxin. Surgery 1997; 122:281-287. (Pubitemid 27383066)
2. Kennedy JA, Clements WD, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, et al. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg 1999; 86:628-633. (Pubitemid 29248355)
3. Guirao X, Lowry SF. Biologic control of injury and inflammation: much more than too little or too late. World J Surg 1996; 20:437-446. (Pubitemid 26138591)
4. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-243. (Pubitemid 27343624)
5. Miller LL. History of isolated liver perfusion and some till unresolved problems. In: Bartosek GA, Miller LL, editors. Isolated liver perfusion and its application. New York: Raven Press. 1972; pp. 1-9.
6. Diamond T, Dolan S, Thompson RL, Rowlands BJ. Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice. Surgery 1990; 108:370-375. (Pubitemid 20255475)
7. Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology 1990; 98:478-485. (Pubitemid 20037933)
8. Greve JW, Gouma DJ, Buurman WA. Complications in obstructive jaundice: role of endotoxins. Scand J Gastroenterol Suppl 1992; 194:8-12. (Pubitemid 23106326)
9. Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut 1998; 42:293-299. (Pubitemid 28212188)
10. Abraham S, Szabo A, Kaszaki J, Varga R, Eder K, Duda E, et al. Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice. Shock 2008; 30:69-74.
11. Yorganci K, Baykal A, Kologlu M, Saribas Z, Hascelik G, Sayek I. Endotoxin challenge causes a proinflammatory state in obstructive jaundice. J Invest Surg 2004; 17:119-126. (Pubitemid 38886030)
12. Iida A, Yoshidome H, Shida T, Kimura F, Shimizu H, Ohsuka M, et al. Does prolonged biliary obstructive jaundice sensitize the liver to endotoxaemia? Shock 2009; 31:397-403.
13. Van Bossuyt H, Desmaretz C, Gaeta GB, Wisse E. The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. J Hepatol 1990; 10:274-279. (Pubitemid 20162732)
14. Saitoh N, Hiraoka T, Uchino R, Miyauchi Y. Endotoxemia and intestinal mucosal drainage in rats. Eur Surg Res 1995; 27:11-18.
15. Clements WD, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg 1998; 128:200-205.
16. Biffl WL, Moore EE, Moore FA, Peterson VM. Interleukin-6 in the injured patient: marker of injury or mediator of inflammation? Ann Surg 1996; 224:647-664. (Pubitemid 26384888)
17. Dawiskiba J, Pawel K, Kwiatkowska D, Zimecki M. Alterations of tumor necrosis factor-alpha and interleukin 6 production and activity of the reticuloendothelial system in experimental jaundice in rats. HPB Surg 2000; 4:11-20.
18. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992; 15:1132-1146.
19. Pain JA. Reticulo-endothelial function in obstructive jaundice. Br J Surg 1987; 74:1091-1094. (Pubitemid 18026776)
20. Meng Y, Gong YC, Dou Y, Li W. Changes of serum cytokines and expression of inducible nitric oxide synthase mRNA by Kupffer cells after relief from obstructive jaundice in rats. J Gastroenterol Hepatol 2009; 24:1064-1069.
21. Gores GJ, Kost LJ, La Russo NF. The isolated perfused rat liver: conceptual and practical considerations. Hepatology 1986; 6:511-527.
22. Draz S, Minami R, Byrield J, Fonkalsrud EW. Biochemical evaluation of hepatic preservation techniques in the isolated rat liver. Surgery 1971; 70:446-451.
23. Vonk RJ, Danhof M, Coenraads T, Van Doorn AB, Keulemans K, Scaf AH, Meijer DK. Influence of bile salts on hepatic transport of dibromosulphthalein. Am J Physiol 1979; 237:E524-E534. (Pubitemid 10174523)
24. Mischinger HJ, Walsh TR, Liu T, Rao PN, Rubin R, Nakamura K, et al. An improved technique for isolated perfusion of rat livers and an evaluation of perfusates. J Surg Res 1992; 53:158-165.
25. Carpino F, Gaudio E, Marinozzi G, Melis M, Motta PM. A scanning and transmission electron microscopic study of experimental extrahepatic cholestasis in the rat. J Submicrosc Cytol 1981; 13:581-598.
26. Tran-Thi TA, Weinhold L, Weinstock C, Hoffmann R, Schulze-Specking A, Northoff H, Decker K. Production of tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the perfused rat liver. Eur Cytokine Netw 1993; 4:363-370. (Pubitemid 24001549)
27. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985; 135:3972-3977. (Pubitemid 16250378)
28. Kennedy JA, Clements WD, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, et al. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg 1999; 86:628-633. (Pubitemid 29248355)
29. Iwai M, Cui TX, Kitamura H, Saito M, Shimazu T. Increased secretion of tumour necrosis factor and interleukin 6 from isolated, perfused liver of rats after partial hepatectomy. Cytokine 2001; 13:60-64. (Pubitemid 32579224)
30. Wu C, Li M, Chen C, Zhang M. Endotoxin-induced liver injury and changes in the levels of plasma tumor necrosis factor-alpha and interleukin-6 in rabbits. Chin Med J (Engl) 1996; 108:548-550.
31. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-664. (Pubitemid 18005583)
32. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-1486.
33. Starnes HF Jr, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, Brennan MF. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988; 82:1321-1325.
34. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989; 170:1627-1633. (Pubitemid 19284562)
35. Van der Poll T, Van Deventer SJ, Hack CE, Wolbink GJ, Aarden LA, Buller HR, ten Cate JW. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 1992; 79:693-698.
36. Lin E, Lowry S. The human response to endotoxin. Sepsis 1998; 2:255-262.
37. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA Jr., Cerami A, et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1998; 166:147-153.
38. Redl H, Schlag G, Bahrami S, Schade U, Ceska M, Stutz P. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 1991; 164:383-388.
39. Biffl WL, Moore EE, Moore FA, Carl VS, Kim FJ, Franciose RJ. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg 1994; 129:1131-1136. (Pubitemid 24335961)
40. Bitterman H, Kinarty A, Lazarovich H, Lahat N. Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J Clin Immunol 1991; 11:184-192.
41. Bordea M, Teleianu C, Popamare A, Vacariu A, Stan C, Iliescu I. Immune mechanisms in the process of hepatopathies chronicization: contribution and role of lymphokines. Rom J Physiol 1995; 32:87-95.
42. Ayala A, Perrin MM, Ertel W, Chaudry IH. Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine 1992; 4:66-75.
43. Busam KJ, Bauer TM, Bauer J, Gerok W, Decker K. Interleukin-6 release by rat liver macrophages. J Hepatol 1990; 11:367-373.
44. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-1128.
45. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factorbeta and interleukin-10. J Biol Chem 1992; 267:23301-23308.
46. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993; 151:6370-6381. (Pubitemid 23340383)
47. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173. (Pubitemid 19138011)
48. Yoshimoto T, Paul WE. CD4pos NK1.1pos T cells promptly produce interleukin 4 in response to in-vivo challenge with anti-CD3. J Exp Med 1994; 179:1285-1295.
49. Kimmings AN, Van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000; 46:725-731. (Pubitemid 30305794)
50. Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, et al. Anti-inflammatory response in patients with obstructive jaundice caused by biliary malignancy. J Gastroenterol Hepatol 2001; 16:467-472. (Pubitemid 32397661)
51. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311-320. (Pubitemid 28067327)
52. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83:113-118. (Pubitemid 24016522)
53. Wakabayashi Y, Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Miyazaki M. Mechanism of neutrophil accumulation in sinusoids after extrahepatic biliary obstruction. Hepatogastroenterology 2008; 55:1179-1183.
54. Ljungdahl M, Osterberg J, Ransjo U, Engstrand L, Haglund U. Inflammatory response in patients with malignant obstructive jaundice. Scand J Gastroenterol 2007; 42:94-102. (Pubitemid 46033052)
55. Van der Gaag NA, Kloek JJ, deCastro SM, Busch OR, Van Gulik TM, Gouma DJ. Preoperative biliary drainage in patients with obstructive jaundice: history and current status. J Gastrointest Surg 2009; 13:814-820.